Literature DB >> 11528563

Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study.

J L García-Garmendia1, C Ortiz-Leyba, J Garnacho-Montero, F J Jiménez-Jiménez, C Pérez-Paredes, A E Barrero-Almodóvar, M Gili-Miner.   

Abstract

Nosocomial bacteremia caused by Acinetobacter baumannii (AB) is of increasing concern in critically ill patients, and the risk factors for this infection are not well established. An inception cohort study in a 40-bed medical and surgical intensive care unit (ICU) at a single institution was conducted during a 2-year period to determine the risk factors for AB nosocomial bacteremia. Risk factors related to the underlying diseases, the clinical picture at admission, and those acquired during the stay in the ICU were recorded upon admission and daily throughout the ICU stay. We defined an "invasive procedures index" as the number of invasive procedures performed every day during the ICU stay before the onset of AB bacteremia divided by the number of days in the ICU before the onset of AB bacteremia. Risk factors that were independently associated with AB bacteremia were immunosuppression, unscheduled admission to the hospital, respiratory failure at ICU admission, previous antimicrobial therapy, previous sepsis in the ICU, and the invasive procedures index.

Entities:  

Mesh:

Year:  2001        PMID: 11528563     DOI: 10.1086/322584

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  55 in total

1.  Longitudinal epidemiology of multidrug-resistant (MDR) Acinetobacter species in a tertiary care hospital.

Authors:  Ji Hoon Baang; Peter Axelrod; Brooke K Decker; Andrea M Hujer; Georgia Dash; Allan R Truant; Robert A Bonomo; Thomas Fekete
Journal:  Am J Infect Control       Date:  2011-08-11       Impact factor: 2.918

2.  Molecular characterization of hand flora and environmental isolates in a community setting.

Authors:  Preeti Pancholi; Mimi Healy; Tracy Bittner; Renee Webb; Fan Wu; Allison Aiello; Elaine Larson; Phyllis Della Latta
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

Review 3.  Global challenge of multidrug-resistant Acinetobacter baumannii.

Authors:  Federico Perez; Andrea M Hujer; Kristine M Hujer; Brooke K Decker; Philip N Rather; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

4.  Distribution and drug resistance of pathogenic bacteria isolated from cancer hospital in 2013.

Authors:  Linjuan Liu; Qi Li; Qingyun Zhang; Guohong Wang; Guobin Xu; Ji Zhang
Journal:  Chin J Cancer Res       Date:  2014-12       Impact factor: 5.087

5.  Acinetobacter baumannii Biofilm Formation in Human Serum and Disruption by Gallium.

Authors:  Federica Runci; Carlo Bonchi; Emanuela Frangipani; Daniela Visaggio; Paolo Visca
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

6.  Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii.

Authors:  Leticia V Bentancor; Ana Camacho-Peiro; Cagla Bozkurt-Guzel; Gerald B Pier; Tomás Maira-Litrán
Journal:  J Bacteriol       Date:  2012-05-18       Impact factor: 3.490

7.  Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action.

Authors:  José María Saugar; María Jesús Rodríguez-Hernández; Beatriz G de la Torre; María Eugenia Pachón-Ibañez; María Fernández-Reyes; David Andreu; Jerónimo Pachón; Luis Rivas
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

8.  Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii.

Authors:  Chen Niu; Katy M Clemmer; Robert A Bonomo; Philip N Rather
Journal:  J Bacteriol       Date:  2008-02-15       Impact factor: 3.490

9.  High and increasing Oxa-51 DNA load predict mortality in Acinetobacter baumannii bacteremia: implication for pathogenesis and evaluation of therapy.

Authors:  Yu-Chung Chuang; Shan-Chwen Chang; Wei-Kung Wang
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

Review 10.  Acinetobacter infections: a growing threat for critically ill patients.

Authors:  M E Falagas; E A Karveli; I I Siempos; K Z Vardakas
Journal:  Epidemiol Infect       Date:  2007-09-25       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.